Providence St. Joseph Health

Providence St. Joseph Health Digital Commons
Providence Pharmacy PGY2 Program at
Providence Medical Group

Oregon Academic Achievement

4-29-2020

Impact of pharmacist-led appointments for hypertension
management in a primary care setting: a retrospective analysis
Anne Marie Thibodeaux
Providence Medical Group, Anne.Thibodeaux@providence.org

Christine Doran
Providence Medical Group, Christine.Doran@providence.org

Ben Rosati
Providence Medical Group, Benjamin.Rosati@providence.org

Follow this and additional works at: https://digitalcommons.psjhealth.org/pharmacy_PGY2
Part of the Pharmacy and Pharmaceutical Sciences Commons

Recommended Citation
Thibodeaux, Anne Marie; Doran, Christine; and Rosati, Ben, "Impact of pharmacist-led appointments for
hypertension management in a primary care setting: a retrospective analysis" (2020). Providence
Pharmacy PGY2 Program at Providence Medical Group. 1.
https://digitalcommons.psjhealth.org/pharmacy_PGY2/1

This Poster is brought to you for free and open access by the Oregon Academic Achievement at Providence St.
Joseph Health Digital Commons. It has been accepted for inclusion in Providence Pharmacy PGY2 Program at
Providence Medical Group by an authorized administrator of Providence St. Joseph Health Digital Commons. For
more information, please contact digitalcommons@providence.org.

RESULTS:

Impact of pharmacist-led
appointments for
hypertension management in
a primary care setting: a
retrospective analysis

Baseline Characteristics
CPS patients
(n=50)

PCP patients
(n=50)

Age, years, mean (range)

67.9 (35-94)

70.7 (46-89)

Age over 75, no. (%)
Sex, female, no. (%)
BMI, average (range)

17 (34)
24 (48)
31.6 (20-54)

17 (34)
24 (48)
31.5 (22-46)

12 (24)
3 (6)
4 (8)
13 (26)
5 (10)

17 (34)
7 (14)
5 (10)
17 (34)
8 (16)

Demographics

Comorbidities, n (%)
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Clinical ASCVD
Atrial fibrillation
Heart failure
Diabetes
CKD

Primary Outcome Data
Hypertension
Metric (%)

BACKGROUND:
- High blood pressure is a major risk factor for
heart disease and stroke, two of the leading
causes of death for all Americans.1
- Optimal blood pressure (BP) management often
requires frequent monitoring and follow-up,
which primary care physicians (PCPs) can have
difficulty maintaining. 2
- Evidence supports pharmacist-led hypertension
(HTN) management, as it can result in BP
reduction.3
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Clinic A

74.7

73.5

Clinic B

72.2

65.5

CPS patients
(n=50)

PCP patients
(n=50)

At goal during initial visit

38

76

At goal during final visit

80

94

Average change in SBP

-17 mmHg

-8 mmHg

Average change in DBP

-5.8 mmHg

-2.9 mmHg

Interventions, %

CPS patients
(n=50)

PCP patients
(n=50)

Medication added

52

26

Medication discontinued
Medication dose
adjustment
Non-HTN medication
intervention
Total # of interventions
per patient,
average (range)

28

20

42

28

22

N/A

2.2 ( 0-7)

N/A

Blood pressure, %

Can pharmacist-led appointments
for blood pressure management
positively impact

METHODOLOGY:
- Primary outcome:
 Hypertension metric inventory, defined as:
o Percentage of patients whose most
recent blood pressure was at goal
 HTN metric goal defined as:
o Age 18-59 years: ≤ 140/90
o Age 60+ years: ≤ 150/90
o Pt w/ diabetes: ≤ 140/90
- Secondary outcomes:
 Patients who had a clinical pharmacy
specialist (CPS) visit for hypertension
between February 2019 to November 2019
were identified
 Chart reviews were utilized to obtain data
 Propensity matching was used to identify an
equivalent number of patients within
included clinics whose HTN was managed by
their PCP
 Two-tail sample t test compared the systolic
BP reduction between the two groups

After CPS-led HTN visits
established

Secondary Outcomes Data

OUTCOMES:
- Primary outcome:
 Evaluate the impact of pharmacist-led HTN
management on HTN metric data
- Secondary outcomes:
 Number of medication interventions made
during each visit
 Change in BP within 4 months compared to
patients being managed by PCP

Before CPS-led HTN
visits established

hypertension metrics?

LIMITATIONS:
- HTN metric definition changed during the study
- Patients seen by CPS only account for a small
percentage of the overall metric population
- HTN metric does not always correlate with
patient-specific BP goal
- Propensity matching did not match groups for
baseline BP

CONCLUSIONS:
- The overall decrease in the HTN metric does
not suggest pharmacist-led appointments can
positively impact the metric; however, changes
in the metric definition interfered with proper
assessment.
- Pharmacists provided an average of 2.2
medication interventions per patient, most
commonly being adding a medication (52%),
dose adjustment (42%), and discontinuation
(28%).
- There was a statistically significant systolic BP
reduction in the CPS group compared to the
PCP group (p = 0.04); however, more patients in
the PCP group were at their BP goal initially.
- Overall, pharmacists were able to optimize
medication regimens during visits, and almost
half of the patients seen by a pharmacist were
able to achieve their BP goal within 4 months.

